Effects of vitamin D on bone and muscle density in myasthenia gravis patients
Recruiting
- Conditions
- myasthenia gravis
- Registration Number
- ACTRN12617000445370
- Lead Sponsor
- Show Chwan Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link vitamin D deficiency to muscle atrophy in myasthenia gravis?
How does vitamin D supplementation compare to bisphosphonates in preventing bone loss for myasthenia gravis patients?
Which biomarkers correlate with improved bone and muscle density following vitamin D treatment in myasthenia gravis?
What are the potential adverse effects of high-dose vitamin D therapy in myasthenia gravis patients with thymic abnormalities?
How do vitamin D analogs synergize with immunosuppressants like prednisone in managing myasthenia gravis-related musculoskeletal complications?